Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Lenalidomide

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCPED15111

    05/18/2017

    A Phase 2, Multicenter, Single-Arm, Open-Label Study to Evaluate the Activity, Safety and Pharmacokinetics of Lenalidomide (REVLIMID?) in Pediatric Subjects from 1 to ≤ 18 Years of Age with Relapsed OR Refractory Acute Myeloid Leukemia

    Treatment

    VICCHEM14131

    11/17/2015

    Phase 1b Study of Carfilzomib Administered Once Weekly in Combination with Lenalidomide and Dexamethasone in Subjects with Multiple Myeloma

    Treatment

    VICCHEMP1558

    10/09/2015

    A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies


    Print this page for your doctor